High Tower Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 79,961 shares of HRMY stock, worth $2.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,961
Previous 17,232
364.03%
Holding current value
$2.81 Million
Previous $519,000
515.41%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.1MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$395 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$205 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$122 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$91.7 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$67.8 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.08B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...